These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30427660)

  • 21. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model.
    Laing ST; Moody MR; Kim H; Smulevitz B; Huang SL; Holland CK; McPherson DD; Klegerman ME
    Thromb Res; 2012 Oct; 130(4):629-35. PubMed ID: 22133272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
    Kajimoto Y; Ohta T; Kuroiwa T
    Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
    Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
    J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage.
    Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T
    Neurol Res; 1998 Oct; 20(7):625-31. PubMed ID: 9785591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases.
    Tadayon A; Jamshidi R; Esmaeili A
    Int J Pharm; 2015 Nov; 495(1):428-438. PubMed ID: 26363110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow.
    Piebalgs A; Xu XY
    J R Soc Interface; 2015 Dec; 12(113):20150949. PubMed ID: 26655469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
    Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
    Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of clot aging and cholesterol content on ultrasound-assisted thrombolysis.
    Zhou Y; Murugappan SK; Sharma VK
    Transl Stroke Res; 2014 Oct; 5(5):627-34. PubMed ID: 24488442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
    Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
    Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.
    Kwon OW; Kang SJ; Lee JB; Lee SC; Yoon YD; Oh JH
    Ophthalmologica; 1998; 212(2):120-5. PubMed ID: 9486552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. tPA Point Mutation at Autolysis Loop Enhances Resistance to PAI-1 Inhibition and Catalytic Activity.
    Peng S; Xue G; Chen S; Chen Z; Yuan C; Li J; Huang M
    Thromb Haemost; 2019 Jan; 119(1):77-86. PubMed ID: 30597502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-Dependent Thrombus Resolution After Tissue-Type Plasminogen Activator in Patients With Stroke and Mice.
    Kim YD; Nam HS; Kim SH; Kim EY; Song D; Kwon I; Yang SH; Lee K; Yoo J; Lee HS; Heo JH
    Stroke; 2015 Jul; 46(7):1877-82. PubMed ID: 25967573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of intracerebral hematoma with stereotactically implanted tissue plasminogen activator polymers in a rabbit model.
    Thai QA; Pradilla G; Legnani FG; Kretzer RM; Hsu W; Tamargo RJ
    J Neurosurg; 2006 Sep; 105(3):424-9. PubMed ID: 16961138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.